[
./indexpag.html
]
Abeome is an emerging biotechnology company dedicated to leveraging its proprietary hybridoma technology to accelerate and improve development of monoclonal antibodies for life sciences and clinical medicine.
[
./company_overviewpag.html
]
[
./teampag.html
]
[
./newspag.html
]
[
./employmentpag.html
]
[
./technologypag.html
]
[
./research_servicespag.html
]
[
./technologypag.html
]
Abeome's DiSH technology is the key to driving unprecedented efficiencies in screening for new targets. Using DiSH, desired monoclonals can be identified using fluorescent-labeled antigens to bind surface- expressed antibodies, making isolation and cloning desired cells significantly easier.
Research and identification of novel/high potential monoclonal antibodies is hampered by a cumbersome, costly and inefficient screening and cloning process.
[
./contact_uspag.html
]
Copyright © 2006 Abeome Corp. All rights reserved.
[
./partneringpag.html
]
[
./newspag.html
]
Click here to see the latest news about Abeome.
[
Web Creator
] [
LMSOFT
]